Urgent Field Safety Notice for MabTrack level infliximab by Sanquin Reagents
2022.03.16
Product group In-vitro diagnostics - immunological products
Reference 02802/22
For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.